Advances in the mechanisms of action of cancer-targeting oncolytic viruses.
Explore this paper's citation graph
Summary
How the knowledge of oncolytic viral specificity and cytotoxicity has advanced in recent years is highlighted with a view to discuss OV in clinical application and the future directions of this field.
- Type
- article
- Published
- 2018-04-01
- Cited by
- 36
- References
- 85
- Access
- Open access
- OpenAlex
- https://openalex.org/W2784551257
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:3950361
Keywords
Oncolytic virus, Virotherapy, Cancer, Radiation therapy, Clinical trial
References
- Gene therapy targeting hepatocellular carcinoma by a dual-regulated oncolytic adenovirus harboring the focal adhesion kinase shRNA.
- Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial.
- Safety and antitumor effect of oncolytic and helper-dependent adenoviruses expressing interleukin-12 variants in a hamster pancreatic cancer model
- A critical role for IL-18 in the proliferation and activation of NK1.1+ CD3- cells.
- Other Novel Therapies: Biomarkers, microRNAs and microRNA Inhibitors, DNA Methylation, Epigenetics, Immunotherapy and Virotherapy.
- p53 as a target for the treatment of cancer.
- The hallmarks of cancer
- Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded
- Tumor angiogenesis: therapeutic implications.
- MicroRNAs in human cancer: from research to therapy
- Vesicular Stomatitis Virus (VSV) Therapy of Tumors
- Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses.
- Comparison of Prostate-Specific Promoters and the Use of PSP-Driven Virotherapy for Prostate Cancer
- Inhibition of retinoblastoma in vitro and in vivo with conditionally replicating oncolytic adenovirus H101.
- Enhanced antitumor response mediated by the codelivery of paclitaxel and adenoviral vector expressing IL-12.
- Treatment of medulloblastoma with oncolytic measles viruses expressing the angiogenesis inhibitors endostatin and angiostatin
- From Scourge to Cure: Tumour-Selective Viral Pathogenesis as a New Strategy against Cancer
- Development of an oncolytic Herpes Simplex Virus using a tumor-specific HIF-responsive promoter
- Going viral with cancer immunotherapy
- MicroRNAs and oncolytic viruses.
Cited by
- The advent of oncolytic virotherapy in oncology: The Rigvir® story
- SOCS4 expressed by recombinant HSV protects against cytokine storm in a mouse model
- New combinational therapies for cancer using modern statistical mechanics
- Oncolytic Viruses and Immune Checkpoint Inhibition: The Best of Both Worlds
- Optimizing oncolytic virotherapy in cancer treatment
- Tumoricidal Stem Cell Therapy Enables Killing in Novel Hybrid Models of Heterogeneous Glioblastoma.
- Cell Death Mechanisms in Esophageal Squamous Cell Carcinoma Induced by Vesicular Stomatitis Virus Matrix Protein
- Oncolytic viruses: what to expect from their use in cancer treatment
- Recent Advances in Molecular Mechanisms of the NKG2D Pathway in Hepatocellular Carcinoma
- The potential use of oncolytic viruses in breast cancer: historical aspects and future prospects (literature review)
- Oncolytic virotherapy: Challenges and solutions.
- Multilevel Targeting of Canine Adenovirus Type 2 (CAV2) to Expand Oncolytic Virotherapy in Canine Tumors
- Implication of heat shock proteins in rotavirus entry into Reh cells.
- Simultaneous Tumor and Stroma Targeting by Oncolytic Viruses
- Delivery routes matter: Safety and efficacy of intratumoral immunotherapy.
- Global Virology III: Virology in the 21st Century
- Combination Therapy of Novel Oncolytic Adenovirus with Anti-PD1 Resulted in Enhanced Anti-Cancer Effect in Syngeneic Immunocompetent Melanoma Mouse Model
- Strategies to Develop Potent Oncolytic Viruses and Enhance Their Therapeutic Efficacy.
- Enhancing the HSV-1-mediated antitumor immune response by suppressing Bach1
- Immune checkpoint inhibitors for PD-1/PD-L1 axis in combination with other immunotherapies and targeted therapies for non-small cell lung cancer
Related papers
- Oncolytic Virotherapy: An Advanced Microbial Approach for the Management of Cancer.
- Oncolytic virotherapy as promising immunotherapy against cancer: mechanisms of resistance to oncolytic viruses.
- Enhancing Oncolytic Virotherapy: Observations from a Voronoi Cell-Based Model.
- Mesenchymal stem cells as carrier cells to enable effective intratumoral delivery of oncolytic virus for oncolytic virotherapy: a systematic review
- Antiglioma oncolytic virotherapy: unattainable goal or a success story in the making?
- A multiscale mathematical model for oncolytic virotherapy.
- Modeling oncolytic virotherapy: is complete tumor-tropism too much of a good thing?
- Oncolytic virotherapy: Challenges and solutions.
- Delivery and Biosafety of Oncolytic Virotherapy